Senior Global Scientific Advisor
Dr. Skolnik is the Norman S. Wikler Professor of Medicine and Director of the Division of Nephrology at the New York University Langone Medical Center. His current research interests are on the regulation and function of the potassium channel KCa3.1 in lymphocyte and mast cell activation, and the role of histidine phosphorylation and dephosphorylation in regulating KCa3.1 and other biological processes. The ultimate goal of these studies are to identify new targets to inhibit lymphocyte and mast cell activation and thereby treat autoimmune disease and allergy and new targets to promote lymphocyte activation to enhance anti-tumor immunity. In addition, Dr. Skolnik’s lab studies autosomal dominant polycystic kidney disease which is the most common hereditary cause of renal failure world wide. Dr. Skolnik has received many awards for his research including election to the American Society of Clinical Investigation, American Association of Physicians, and the Interurban Clinical Club to name a few and currently serves on the executive program and award’s committees of the American Society of Nephrology.